Literature DB >> 30694044

Functional Interrogation of a Depression-Related Serotonergic Single Nucleotide Polymorphism, rs6295, Using a Humanized Mouse Model.

Ashley M Cunningham1,2, Tabia L Santos1, Vanessa A Gutzeit1, Heather Hamilton2, René Hen1, Zoe R Donaldson2.   

Abstract

The serotonin 1A receptor (5-HT1A) system has been extensively implicated in modulating mood and behavior. Notably, 5-HT1A levels in humans display remarkable variation, and differences in receptor levels have been linked with a variety of psychiatric disorders. Further, reduction of receptor levels by 30-50% in mice suggests that changes in receptor levels that model existing human variation are sufficient to drive behavioral alterations. As a result, genetic mechanisms that modulate human 5-HT1A levels may be important for explaining individual differences in mood and behavior, representing a potential source of psychiatric disease risk. One common genetic variant implicated in differential 5-HT1A levels is the G/C single nucleotide polymorphism (SNP) rs6295, located upstream of the human 5-HT1A gene. This SNP differentially binds the transcription factor, NUDR/Deaf1, leading to cell-type specific effects on transcription in vitro. To investigate the direct effects of this SNP in the heterogeneous cellular context of the brain, we generated humanized transgenic mice using a design that maximized the local transcriptional landscape of the human HTR1A gene while also controlling for effects of genomic insertion location. We integrated a 180 kb human bacteria artificial chromosome (BAC) transgene containing G- and C-alleles of rs6295 flanked by FRT or loxP sites. Subsequent deletion of each allele by Cre- or Flp-recombinase resulted in rs6295G and C alleles in the same genomic location. These alleles were bred onto a 5-HT1A null mouse such that the human BAC was the sole source of 5-HT1A in these mice. We generated three separate lines, two of which had detectable human 5-HT1A levels in the brain, although none displayed expression in the raphe. Of these, one line exhibited rs6295-dependent differences in 5-HT1A levels and differences in behavior, even though the overall levels were considerably lower than native expression levels. The line-dependent effect of rs6295 on protein levels and behavior may depend upon differences in background genetic factors or different insertion sites across each line. This work confirms that relatively subtle differences in 5-HT1A levels can contribute to differences in behavior and highlights the challenges of modeling human noncoding genetic variation in mice.

Entities:  

Keywords:  5-HT1A; BAC transgenic; HTR1A; anxiety; depression; genetic variation; humanized; rs6295

Mesh:

Substances:

Year:  2019        PMID: 30694044      PMCID: PMC6878663          DOI: 10.1021/acschemneuro.8b00638

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  51 in total

1.  Increased serotonin-1A (5-HT1A) autoreceptor expression and reduced raphe serotonin levels in deformed epidermal autoregulatory factor-1 (Deaf-1) gene knock-out mice.

Authors:  Margaret Czesak; Brice Le François; Anne M Millar; Mariam Deria; Mireille Daigle; Jane E Visvader; Hymie Anisman; Paul R Albert
Journal:  J Biol Chem       Date:  2012-01-09       Impact factor: 5.157

2.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

Authors:  S Ramboz; R Oosting; D A Amara; H F Kung; P Blier; M Mendelsohn; J J Mann; D Brunner; R Hen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

3.  Differential control of learning and anxiety along the dorsoventral axis of the dentate gyrus.

Authors:  Mazen A Kheirbek; Liam J Drew; Nesha S Burghardt; Daniel O Costantini; Lindsay Tannenholz; Susanne E Ahmari; Hongkui Zeng; André A Fenton; René Hen
Journal:  Neuron       Date:  2013-03-06       Impact factor: 17.173

4.  Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice.

Authors:  L K Heisler; H M Chu; T J Brennan; J A Danao; P Bajwa; L H Parsons; L H Tecott
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

5.  Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide.

Authors:  Sylvie Lemonde; Gustavo Turecki; David Bakish; Lisheng Du; Pavel D Hrdina; Christopher D Bown; Adolfo Sequeira; Neena Kushwaha; Stephen J Morris; Ajoy Basak; Xiao-Ming Ou; Paul R Albert
Journal:  J Neurosci       Date:  2003-09-24       Impact factor: 6.167

Review 6.  Transcriptional regulation at a HTR1A polymorphism associated with mental illness.

Authors:  Brice Le François; Margaret Czesak; Dominik Steubl; Paul R Albert
Journal:  Neuropharmacology       Date:  2008-06-29       Impact factor: 5.250

7.  A new positive/negative selection scheme for precise BAC recombineering.

Authors:  Shuwen Wang; Yuanjun Zhao; Melanie Leiby; Jiyue Zhu
Journal:  Mol Biotechnol       Date:  2009-01-22       Impact factor: 2.695

Review 8.  10 Years of GWAS Discovery: Biology, Function, and Translation.

Authors:  Peter M Visscher; Naomi R Wray; Qian Zhang; Pamela Sklar; Mark I McCarthy; Matthew A Brown; Jian Yang
Journal:  Am J Hum Genet       Date:  2017-07-06       Impact factor: 11.025

Review 9.  Genomically humanized mice: technologies and promises.

Authors:  Anny Devoy; Rosie K A Bunton-Stasyshyn; Victor L J Tybulewicz; Andrew J H Smith; Elizabeth M C Fisher
Journal:  Nat Rev Genet       Date:  2011-12-16       Impact factor: 53.242

10.  Serotonin 1A receptor-mediated signaling through ERK and PKCα is essential for normal synaptogenesis in neonatal mouse hippocampus.

Authors:  A Mogha; S R Guariglia; P R Debata; G Y Wen; P Banerjee
Journal:  Transl Psychiatry       Date:  2012-01-10       Impact factor: 6.222

View more
  6 in total

Review 1.  Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Authors:  Paul R. Albert; Brice Le François; Faranak Vahid-Ansari
Journal:  J Psychiatry Neurosci       Date:  2019-05-01       Impact factor: 6.186

2.  HTR1A Gene Polymorphism in Type 2 Diabetes Mellitus Comorbid with Major Depressive Disorder in a Chinese Population.

Authors:  Dilixia Simayi; Yaqun Guan
Journal:  Diabetes Metab Syndr Obes       Date:  2022-05-25       Impact factor: 3.249

3.  Sperm transcriptional state associated with paternal transmission of stress phenotypes.

Authors:  Ashley M Cunningham; Deena M Walker; Aarthi Ramakrishnan; Marie A Doyle; Rosemary C Bagot; Hannah M Cates; Catherine J Peña; Orna Issler; Casey Lardner; Caleb Browne; Scott J Russo; Li Shen; Eric J Nestler
Journal:  J Neurosci       Date:  2021-06-07       Impact factor: 6.167

4.  Genetic Polymorphisms Affecting IDO1 or IDO2 Activity Differently Associate With Aspergillosis in Humans.

Authors:  Valerio Napolioni; Marilena Pariano; Monica Borghi; Vasilis Oikonomou; Claudia Galosi; Antonella De Luca; Claudia Stincardini; Carmine Vacca; Giorgia Renga; Vincenzina Lucidi; Carla Colombo; Ersilia Fiscarelli; Cornelia Lass-Flörl; Alessandra Carotti; Lucia D'Amico; Fabio Majo; Maria Chiara Russo; Helmut Ellemunter; Angelica Spolzino; Paolo Mosci; Stefano Brancorsini; Franco Aversa; Andrea Velardi; Luigina Romani; Claudio Costantini
Journal:  Front Immunol       Date:  2019-05-07       Impact factor: 7.561

5.  Associations Between a Polymorphism in the Rat 5-HT1A Receptor Gene Promoter Region (rs198585630) and Cognitive Alterations Induced by Microwave Exposure.

Authors:  Haijuan Li; Yu Gao; Yong Zou; Simo Qiao; Weijia Zhi; Lizhen Ma; Xinping Xu; Xuelong Zhao; Junhua Zhang; Lifeng Wang; Xiangjun Hu
Journal:  Front Public Health       Date:  2022-02-17

6.  Synergistic antidepressant- and anxiolytic-like effects of harmaline along with cinanserin in acute restraint stress-treated mice.

Authors:  Sajedeh Mosaffa; Hanieh Ahmadi; Fatemeh Khakpai; Mohaddeseh Ebrahimi-Ghiri; Mohammad-Reza Zarrindast
Journal:  Psychopharmacology (Berl)       Date:  2020-11-14       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.